Pilot Study of the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Smith & Nephew, Inc.
Information provided by (Responsible Party):
Smith & Nephew, Inc.
ClinicalTrials.gov Identifier:
First received: January 9, 2013
Last updated: November 18, 2015
Last verified: November 2015
The primary objective of this study is to obtain safety data on the use of the ULTRABRAID PLUS SUTURE, and to assess the preliminary effectiveness of the use of the ULTRABRAID PLUS SUTURE in comparison to the ULTRABRAID SUTURE in patients undergoing rotator cuff repair.

Condition Intervention
Rotator Cuff Tear

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Two-Arm, Single Blind, Randomized Pilot Study on the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff

Resource links provided by NLM:

Further study details as provided by Smith & Nephew, Inc.:

Primary Outcome Measures:
  • Rotator Cuff Integrity [ Time Frame: 6 months post-operatively ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Rotator Cuff Integrity [ Time Frame: 1, 3 and 6 weeks and 3 and 12 months post-operatively ] [ Designated as safety issue: No ]
  • Change in post-surgery tissue thickness, rotator cuff integrity, tendon echogenicity and muscle atrophy [ Time Frame: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively ] [ Designated as safety issue: No ]
    Compared to Baseline (preop)

  • Change in Vascularity [ Time Frame: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively ] [ Designated as safety issue: No ]
    Compared to Baseline (preop)

  • Change in Constant Shoulder Assessment [ Time Frame: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively ] [ Designated as safety issue: No ]
    Compared to Baseline (preop)

  • Change in Western Ontario Rotator Cuff Index [ Time Frame: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively ] [ Designated as safety issue: No ]
    Compared to Baseline (preop)

  • Rehabilitation [ Time Frame: 3 and 6 weeks and 3, 6 and 12 months post-operatively ] [ Designated as safety issue: No ]
    • Time to active-assisted rehab exercises
    • Time to isometric rehab exercises
    • Time to discontinuation of arm sling

  • Labs [ Time Frame: 1, 3 and 6 weeks (optional 3, 6 and 12 months) post-operatively ] [ Designated as safety issue: No ]
    Compared to Baseline (preop) Note: If levels do not return to baseline, tests will continue beyond 6 weeks

  • Adverse Events [ Time Frame: Surgery and 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 80
Study Start Date: February 2013
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Rotator Cuff Repair with ULTRABRAID PLUS SUTURE
Rotator Cuff Repair with ULTRABRAID SUTURE


Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria (Subjects must meet ALL of the following criteria):

  • Male or female, aged 18 to 70 years at the time of surgery
  • Willing and able to give voluntary informed consent to participate in this investigation
  • Small (<1cm), Medium (1-3cm) or large (>3-5cm) tear of the supraspinatus tendon, which may or may not include the infraspinatus tendon of the rotator cuff. Tear size will be based on area of longest dimension as evidenced by clinical examination and diagnostic imaging prior to surgery, with the definitive measurement confirmed at surgery
  • Tear requires repair within two years of initial diagnosis
  • Tear must be anatomically repairable (must be able to get tendon back to the medial position on the footprint and at least back to the tuberosity)
  • Willing and able, in the opinion of the Investigator, to cooperate with study procedures, and willing to return to study site for physical therapy and all post-operative study visits

Exclusion Criteria (Subjects must not meet ANY of the following criteria):

  • Tears involving tendons other than the supraspinatus and infraspinatus
  • Partial thickness tears of the rotator cuff (tear must be full thickness)
  • Evidence of acute trauma including fracture or dislocation of the shoulder joint
  • Chronic retraction
  • Evidence of active infection, osteomyelitis, sepsis or distant infection which could spread to the index joint
  • Subject has had previous rotator cuff, arthroplasty or fracture procedures on the operative shoulder
  • Subject has had acromioplasty or diagnostic arthroscopy on the operative shoulder within one (1) year prior to scheduled surgery date
  • Evidence of osteomalacia or other metabolic bone disorder(s) which may impair bone or soft tissue function
  • Evidence of other significant shoulder pathology including (Type II-IV lesion, Bankart lesion, Hill Sachs lesion)
  • Patient has grade 4 changes to articular cartilage in operative shoulder
  • Inflammatory arthropathies
  • Significant muscle paralysis of the shoulder girdle.
  • Painful pathologies of the cervical spine
  • Comminuted bone surface, which would compromise secure anchor fixation.
  • Subject has a known sensitivity to implant materials, including sodium butyrate.
  • Non-surgical rotator cuff associated treatment, such as corticosteroid injection, within one (1) month prior to scheduled surgery date
  • Participating in another investigational trial or ongoing study that would interfere with the assessment of the primary and secondary outcomes
  • Female patient who is pregnant, nursing, or of childbearing potential while not practicing effective contraceptive methods
  • Currently known to abuse drugs or alcohol which could affect follow-up care or treatment outcomes
  • Current smoker
  • Major psychiatric illness, developmental handicap or inability to read and understand the English language
  • Major medical illness that would preclude undergoing surgery
  • Known to be involved in any active injury litigation claims relating to the study shoulder
  • Unwilling or unable to be assessed according to study protocol for one year following surgery
  • Patient requires a concomitant SLAP repair procedure in operative shoulder
  • Surgeon plans to use transosseous sutures in the study procedure
  • Surgeon plans to use a Platelet Rich Plasma product or another therapy intended to augment healing of the rotator cuff in the study procedure
  • Protocol specified surgical technique cannot be followed for this subject
  • Rotator cuff repair will be done via open (as opposed to arthroscopic) procedure
  • Any other reason (in the judgment of the investigator)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01767740

Contact: Sheri Mersch 901-399-6422 sheri.mersch@smith-nephew.com
Contact: Cathy Newbill 901-399-6422 cathy.newbill@smith-nephew.com

Canada, British Columbia
University of British Columbia Withdrawn
Vancouver, British Columbia, Canada, V6T 2B5
Canada, Ontario
Innovation Science and Medicine Recruiting
Burlington, Ontario, Canada, L7R 4C7
Contact: Anne Dang, CCPA    905-333-5100 ext 2      
Principal Investigator: Benjamin Smith, MD         
Fowler Kennedy Sport Medicine Clinic Recruiting
London, Ontario, Canada, N6A 3K7
Contact: Alliya Remtulla    (519) 661 2111 ext 87528    aremtul@uwo.ca   
Principal Investigator: Robert Litchfield, MD FRCSC         
Sub-Investigator: Kevin Willits, MD         
St. Josephs Hospital Recruiting
London, Ontario, Canada, N6A 4L6
Contact: Kate Kelly    (519) 646-6100 ext 64640    Kate.Kelly@sjhc.london.on.ca   
Sub-Investigator: George Athwal, MD, FRCSC         
Sub-Investigator: Kenneth Faber, MD, FRCSC         
Sub-Investigator: Marie-Eve LaBel, MD, FRCSC         
Sub-Investigator: Darren Drosdowech, MD, FRCSC         
Women's College Hospital Recruiting
Toronto, Ontario, Canada, M5C 1R6
Contact: Ryan Khan    (416) 864-6060      
Principal Investigator: Daniel Whelan, MD         
Sponsors and Collaborators
Smith & Nephew, Inc.
Principal Investigator: Robert Litchfield, MD, FRCSC Fowler Kennedy Sports Medicine Clinic
  More Information

No publications provided

Responsible Party: Smith & Nephew, Inc.
ClinicalTrials.gov Identifier: NCT01767740     History of Changes
Other Study ID Numbers: 15001105 
Study First Received: January 9, 2013
Last Updated: November 18, 2015
Health Authority: Canada: Health Canada

Keywords provided by Smith & Nephew, Inc.:
Rotator Cuff Tear
Supraspinatus Tear

ClinicalTrials.gov processed this record on February 10, 2016